FDA Approved: BRIVIACT — Original Application (UCB, Inc.)

View source ↗

Summary

The FDA approved Briviact (brivaracetam) as an adjunctive treatment for partial-onset seizures in adults and in children aged 4 years and older.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Briviact (brivaracetam)

Snippet

ORIG AP for BRIVIACT (BRIVARACETAM)